Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: Paradoxical loss of estrogen receptorα expression during tumor progression

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6901-6910

  Yoshidome, Katsuhide ^a   Shibata, Masa Aki ^a   Couldrey, Christine ^a   Korach, Kenneth S ^b   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARIECTOMY; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, VIRAL, TUMOR; BLOTTING, NORTHERN; BLOTTING, WESTERN; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHORYLATION; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034671471     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cancer statistics
2. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
3. Epidemiology. Search for a killer: Focus shifts from fat to hormones
4. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer
5. Steroid receptors and other prognostic factors in primary breast cancer
6. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian vires 40 large tumor antigen fusion gene
7. Transgenic mouse models of breast cancer
8. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
9. p53-Independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma
10. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
11. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
12. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting
13. Reproductive phenotypes in the estrogen receptor-α knockout mouse
14. Insights from the study of animals lacking functional estrogen receptor
15. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-α
16. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
17. Androgenic induction of cystatin-related protein and the C3 component of prostatic binding protein in primary cultures from the rat lacrimal gland
18. Analysis of regulatory sequences in androgen-responsive genes
19. Response elements of the androgen-regulated C3 gene
20. Insights from the study of animals lacking functional estrogen receptor
21. Analysis of mammographic density and breast cancer risk from digitized mammograms
22. Mammographic breast density during hormone replacement therapy: Differences according to treatment
23. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators
24. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
25. Cloning of a novel receptor expressed in rat prostate and ovary
26. Expression of estrogen receptor-β in human breast tumors
27. Estrogen receptor-β mRNA variants in human and murine tissues
28. Amplification of Ki-ras, and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice
29. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage